Jazz Pharmaceuticals plc — Director's Dealing 2010

Jun 8, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-06-04

Reporting Person: BERNS PAUL L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-04	Option (right to buy)	$7.59	A	30000	Acquired	2020-06-03	Common Stock (30000)	Direct

Footnotes

F1: One-third of the option shares shall vest on June 4, 2011 and the balance of the option shares shall vest in a series of twenty-four (24) successive equal monthly installments thereafter.